Delivery Order SPE2DB20D2104-SPE2DB25FMCSG
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.48 Firm Fixed Price Delivery Order is for the supply of Adzenys XR-ODT 15.7 mg Tablet UD 30s, a medication used to treat various medical conditions. The contract has a completion date of December 17, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.52 firm fixed-price delivery order is for the supply of Adzenys XR-ODT 12.5 mg tablets, with a completion date of July 5, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,514.93, is a delivery order for the supply of Adzenys XR-ODT 18.8 mg tablet medication. The contract has an ultimate completion date of January 30, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Adzenys XR ODT tablets (9.4 mg). The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The current contract award is for $7,368.25 and has a completion date of July 26, 2024. The contract has a...
- This federal contract award is for the delivery of Adzenys XR ODT tabs 1's 15.7mg to the Medical Supply Chain unit of the Defense Logistics Agency (DLA), a defense agency. The $2,499.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,701.66, is a delivery order for the supply of 4,566,828,735 units of Adzenys XR ODT Tabs 1's 9.4mg. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
- This federal contract award, valued at $3,937.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adzenys XR-ODT 9.4 mg tablet in 30-unit doses. This contract is a delivery order under a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.31 Firm Fixed Price delivery order is for ADZENYS XR-ODT 12.5 MG TABLET UD 30S, with a completion date of December 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,336.24 firm-fixed-price contract is for the supply of the prescription drug Adzenys XR-ODT 12.5 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a wide range of medical commodities to support...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.93 contract is for the supply of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMCSGDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Adzenys XR-ODT 18.8 mg tablets. The $1,362.90 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order is for the supply of the specified pharmaceutical product, with an ultimate completion date of November 25, 2024. AmerisourceBergen maintains a significant federal contracting presence, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through its established supply chain and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/22/24 |